[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

4 clusters · 12 sources · 4 days · First seen · Last updated

CPHI Milan 2026 pharmaceutical conference

Overview

The CPHI Milan 2026 conference, held at Fiera Milano from October 6 to 8, serves as a major international gathering for the pharmaceutical and biotech industries. The event is expected to host over 62,000 visitors and 2,400 exhibitors from more than 166 countries.

A key feature of this edition is the inaugural CPHI Sustainability Summit, a two-day program involving over 300 companies. The summit focuses on practical implementation of sustainability, including decarbonizing manufacturing, green chemistry, sustainable packaging, and procurement. Supported by organizations such as AstraZeneca, SK Pharmteco, and Sharp, the summit aims to transition sustainability from corporate commitments to actionable industry practices.

Various industry participants are utilizing the event to showcase specialized services and technologies. West Pharmaceutical Services is presenting its self-injection systems portfolio, while Divasa-Farmavic is also maintaining a presence. Several companies are leveraging the exhibition to expand their Contract Development and Manufacturing Organization (CDMO) and Active Pharmaceutical Ingredient (API) footprints, including Yuhan Corporation and ST Pharm.

During the event, the Greek pharmaceutical industry demonstrated its international competitiveness through the participation of 31 member companies from the Hellenic Association of Pharmaceutical Companies. Theodoros Tryfon, President of the Hellenic Association of Pharmaceutical Companies, stated that the industry’s manufacturing strength is a “strategic national asset,” noting that significant investments contribute to economic growth and the security of the pharmaceutical supply chain for Greece and Europe. The Greek sector is currently implementing an investment program exceeding €1.8 billion to enhance production, R&D, and technological infrastructure.

Entities

CPHI Milan 2026 · Yuhan Corporation · ST Pharm · Theodoros Tryfon · Hellenic Association of Pharmaceutical Companies

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. [BUSINESS] 2 sources
    Greek pharmaceutical industry showcases growth at CPHI Milan

    Thirty-one Greek pharmaceutical companies showcased their international competitiveness at the CPHI 2026 exhibition in Milan, supported by over €1.8 billion in industry investments.

  2. [BUSINESS] 2 sources
    ST Pharm promotes oligonucleotide CDMO business at CPHI Worldwide 2026

    ST Pharm showcased its oligonucleotide CDMO capabilities at CPHI Worldwide 2026 in Milan, seeking new global partnerships and leveraging its newly operational second production facility.

  3. [BUSINESS] 5 sources
    Yuhan Corporation to showcase CDMO capabilities at CPHI Milan 2026

    Yuhan Corporation is showcasing its CDMO capabilities and R&D pipeline at CPHI Milan 2026 to strengthen global partnerships and expand its international pharmaceutical market presence.

  4. [BUSINESS] 5 sources
    CPHI Milan 2026 to host global pharmaceutical industry leaders

    CPHI Milan 2026 will host over 62,000 visitors and feature an inaugural Sustainability Summit focused on decarbonization and green chemistry within the pharmaceutical supply chain.

Sources

bosa.co.kr · dawaanews.com · diarioveterinario.com · drug-dev.com · europesays.com · iatronet.gr · iatropedia.gr · joongboo.com · m.sportalkorea.com · nouvelles-du-monde.com · sateconomy.co.kr · thebionews.net

This summary has been updated 2 times: see revision history